細胞治療CLDX
那斯達克 · USD
25.57
+0.43
(+1.71%)
盤中 01/21 10:44 (UTC+8)
01/21 10:44 (UTC+8)
細胞治療CLDX
25.57
+0.43
(+1.71%)
財務數據
損益表
- 0.00
- 0.02
- 0.04
- 0.00
- 0.02
- 0.03
- 0.01
- 0.01
- 0.01
- -
- -72.39
- 468.54
- 172.13
- -96.22
- 1501.28
- 27.74
- -63.18
- -40.85
- 4.89
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | - | 729 | 695 | 1,175 | 3,191 | 2,498 | 156 | 4,131 | 1,518 | 267 |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | 729 | 695 | 1,175 | 3,191 | 2,498 | 156 | 4,131 | 1,518 | 267 |
營業費用 | 73,617 | 64,587 | - | - | - | - | - | 51,758 | 42,757 | 33,472 |
研發費用 | 62,931 | 54,196 | 52,614 | 46,939 | 45,263 | 39,687 | 31,661 | 30,426 | 34,536 | 26,251 |
推銷及管理費用 | 10,686 | 10,391 | 10,820 | 10,263 | 10,054 | 9,128 | 9,103 | 8,832 | 8,221 | 7,221 |
非經常性項目費用 | - | - | - | - | - | - | - | 12,500 | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -73,617 | -63,858 | -62,739 | -56,027 | -52,126 | -46,317 | -40,608 | -47,627 | -41,239 | -33,205 |
其他收入及費用 | 6,573 | 7,258 | 8,943 | 8,935 | 10,005 | 10,475 | 7,800 | 4,321 | 2,979 | 2,703 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | -67,044 | -56,600 | -53,796 | -47,092 | -42,121 | -35,842 | -32,808 | -43,306 | -38,260 | -30,502 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -67,044 | -56,600 | -53,796 | -47,092 | -42,121 | -35,842 | -32,808 | -43,306 | -38,260 | -30,502 |
基本每股稅後盈餘(元) | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | - | -0.81 | -0.65 |
稀釋每股稅後盈餘(元) | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
基本平均股數(千股) | 66420.00 | 66392.00 | 66383.00 | 66353.00 | 66294.00 | 66019.00 | 58871.00 | - | 47261.00 | 47253.00 |
稀釋平均股數(千股) | 66420.00 | 66392.00 | 66383.00 | 66353.00 | 66294.00 | 66019.00 | 58871.00 | - | 47261.00 | 47253.00 |
還原基本每股稅後盈餘(元) | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | - | -0.81 | -0.65 |
還原稀釋每股稅後盈餘(元) | -1.01 | -0.85 | -0.81 | -0.71 | -0.64 | -0.54 | -0.56 | -0.84 | -0.81 | -0.65 |
還原基本平均股數(千股) | 66,420 | 66,392 | 66,383 | 66,353 | 66,294 | 66,019 | 58,871 | - | 47,261 | 47,253 |
還原稀釋平均股數(千股) | 66,420 | 66,392 | 66,383 | 66,353 | 66,294 | 66,019 | 58,871 | - | 47,261 | 47,253 |
EBITDA(千元) | -67,238 | -57,415 | -55,196 | -49,636 | -45,668 | -39,785 | -35,346 | -44,726 | -39,120 | -30,906 |